Shruti Sharma

ORCID: 0000-0003-0446-2942
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Cancer and Skin Lesions
  • Cutaneous lymphoproliferative disorders research
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Genetic and rare skin diseases.
  • Urologic and reproductive health conditions
  • Monoclonal and Polyclonal Antibodies Research
  • Nonmelanoma Skin Cancer Studies
  • Vascular Tumors and Angiosarcomas
  • Cutaneous Melanoma Detection and Management
  • Cancer Genomics and Diagnostics
  • Mosquito-borne diseases and control
  • Dermatological and Skeletal Disorders
  • Oral Health Pathology and Treatment
  • Acne and Rosacea Treatments and Effects
  • Dermatologic Treatments and Research
  • Tuberculosis Research and Epidemiology
  • Atrial Fibrillation Management and Outcomes
  • Streptococcal Infections and Treatments
  • Bladder and Urothelial Cancer Treatments
  • Diverse Scientific Research Studies
  • Infectious Diseases and Mycology
  • Autoimmune and Inflammatory Disorders
  • Galectins and Cancer Biology

National Institute of Pathology
2017-2025

Indian Council of Medical Research
2012-2025

Safdarjang Hospital
2012-2025

Ministry of Health and Family Welfare
2022-2024

Narsee Monjee Institute of Management Studies
2024

Sharda University
2023-2024

Post Graduate Institute of Medical Education and Research
1988-2024

University of Modern Sciences
2024

IMS Unison University
2023-2024

Natera (United States)
2019-2024

BackgroundAsthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if worldwide burden of asthma symptoms changing.MethodsThis updated cross-sectional used same methods as International and Allergies Childhood (ISAAC) III. were assessed from centres that completed GAN ISAAC (1993–95), III (2001–03), or both. We included individuals two age groups (children aged 6–7 years adolescents 13–14 years) who self-completed...

10.1016/s0140-6736(21)01450-1 article EN cc-by The Lancet 2021-10-01

The anonymous nature of darknets is commonly exploited for illegal activities. Previous research has employed machine learning and deep techniques to automate the detection darknet traffic in an attempt block these criminal This aims improve by assessing a wide variety classification such underlying application types. We find that Random Forest model outperforms other state-of-the-art used prior work with CIC-Darknet2020 dataset. To evaluate robustness our classifier, we obfuscate select...

10.1016/j.cose.2023.103098 article EN cc-by Computers & Security 2023-01-13

Abstract Introduction Personalized and tumor-informed circulating tumor DNA (ctDNA) testing is feasible allows for molecular residual disease (MRD) identification in patients with pancreatic ductal adenocarcinoma (PDAC). Methods In this retrospective analysis of commercial cases from multiple US institutions, personalized, tumor-informed, whole-exome sequenced, germline-controlled ctDNA levels were quantified analyzed PDAC. Plasma samples (n = 1329) 298 clinically validated collected at...

10.1093/oncolo/oyae155 article EN cc-by The Oncologist 2024-07-17

Significance Na + -coupled symporters use the cellular gradient to power transport of physiologically important molecules across lipid membrane. However, mechanism by which binding and dissociation drive remains undefined. This work investigated /hydantoin transporter Mhp1, a member LeuT-fold class transporters, describe conformations sampled during its cycle elucidate ligand-induced shifts in conformational equilibrium. The results this study suggest that Mhp1 isomerization between inward-...

10.1073/pnas.1410431111 article EN Proceedings of the National Academy of Sciences 2014-09-29

Abstract Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We established lymphoma patient-derived xenograft (PDX) models assess their ability mimic tumor biology identify patient treatment options. Experimental Design: the PDX from 16 patients diffuse large lymphoma, mantle cell follicular marginal zone or Burkitt by inoculating cells into a human bone chip implanted mice. subjected...

10.1158/1078-0432.ccr-16-2703 article EN Clinical Cancer Research 2017-03-28

Despite curative-intent radical cystectomy (RC), patients with muscle-invasive bladder cancer (MIBC) are at high risk of recurrence. Biomarkers urgently needed to refine prognostication and selection appropriate perioperative systemic therapies. Our aim was evaluate the prognostic predictive value tumor-informed circulating tumor DNA (ctDNA) results in a multicenter cohort who underwent RC.

10.1016/j.euo.2024.07.001 article EN cc-by-nc-nd European Urology Oncology 2024-07-01

Background. Artemisinin-based combination therapy is the first-line treatment for uncomplicated falciparum malaria. This study assessed antimalarial efficacy and safety of a 150 mg arterolane maleate 750 piperaquine phosphate (AM-PQP) in comparison to Coartem (artemether lumefantrine) patients with acute P. Methods. In this open-label, randomized, multicentric, parallel group clinical trial, 240 were randomized receive AM-PQP (160 patients) or (80 patients). Patients monoinfection initial...

10.1093/cid/cis475 article EN Clinical Infectious Diseases 2012-05-14

To compare the free and total plasma drug concentrations of rifampicin (RMP), isoniazid pyrazinamide in subjects with or without anti-tuberculosis drug-induced hepatotoxicity (DIH).A 110 tuberculosis (TB) patients were administered daily treatment prospectively followed for development DIH. Plasma levels measured at 0, 1, 2 4 h on days 7 14 treatment. 15 who developed DIH (cases) compared 95 did not (controls).Female sex, body mass index < 17 kg/m(2) baseline serum albumin g/dl predicted...

10.5588/ijtld.13.0128 article EN The International Journal of Tuberculosis and Lung Disease 2014-01-10

Abstract Inhibition of B-cell receptor (BCR) signaling through the BTK inhibitor, ibrutinib, has generated a remarkable response in mantle cell lymphoma (MCL). However, approximately one third patients do not respond well to drug, and disease relapse on ibrutinib is nearly universal. Alternative therapeutic strategies aimed prevent overcome resistance are needed. We compared contrasted effects selinexor, selective inhibitor nuclear export, with six MCL lines that display differential...

10.1158/1535-7163.mct-17-0789-atr article EN Molecular Cancer Therapeutics 2018-12-01

Chikungunya fever is a benign and self-limiting disease caused by an RNA virus belonging to genus alphavirus transmitted infected Aedes mosquitoes. However, number of atypical presentations involving various systems have been reported. Among the neurological complications, encephalitis, myelitis, Guillain-Barre syndrome optic neuritis are commonly seen. its presentation as isolated inflammatory myositis causing quadriplegia extremely rare. We report 35-year-old woman with chikungunya-induced...

10.1177/0049475519843781 article EN Tropical Doctor 2019-04-24

With the current pandemic of novel coronavirus disease 2019 (COVID-19) in hand, researchers around globe are dexterously working to find best suitable drug candidates and overcome vaccination-related challenges, achieve efficient control over second surge COVID-19. The medical consultants time again have been reiterating need abide by precautionary steps prevent spread maintaining social distancing when outside, sanitizing hands regularly, wearing masks gloves. They also suggest taking a...

10.1177/1934578x211031707 article EN cc-by-nc Natural Product Communications 2021-09-01

Squamous cell carcinoma (SCC) of a nail unit is an uncommon tumour with low metastatic potential. These tumours are commonly misdiagnosed due to their variable presentation. We report case 53-year-old female presenting solitary, painless growth bleeding tendency, present over her right index finger, persisting for 4 years. Histopathological examination confirmed the diagnosis SCC. This aims highlight clinical presentation, diagnostic approach and treatment SCC in unusual location,...

10.25259/jons_6_2024 article EN 2025-02-04

In the current scenario, treatment of Post Kala Azar Dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over years, there has been a gradual decline in efficacy miltefosine and rise permanent loss vision. Moreover, non-endemic states, not freely available. view this, we attempted two step regimen itraconazole to treat patients PKDL diagnosed on histopathology as well PCR. We found this be highly effective with complete recovery.

10.4103/jvbd.jvbd_205_24 article EN cc-by-nc-sa Journal of Vector Borne Diseases 2025-02-12

10.25259/ijdvl_1790_2024 article EN Indian Journal of Dermatology Venereology and Leprology 2025-02-28

Dermal melanocytoses are characterised by the presence of spindle-shaped melanocytes in dermis. The common forms, such as Mongolian spots, and nevi Ota or Ito, present from birth puberty, while acquired dermal appear adulthood rare. They frequently misdiagnosed lichen planus pigmentosus melasma leading to delay treatment. This study reports five cases unilateral nevus India, with an analysis their dermoscopic histopathological features.

10.25259/ijpgd_235_2024 article EN Indian Journal of Postgraduate Dermatology 2025-04-04

Abstract Background: Tumor-informed circulating tumor (ct) DNA testing is recognized as a powerful predictor of CRC recurrence. However, the benefit systemic therapy to prevent or delay clinical recurrence in patients (pts) with molecular after curative surgery remains uncertain. Methods: Pts who had undergone resection primary and/or metastatic sites + standard care (SoC) adjuvant treatment, if applicable, were enrolled ALTAIR study they (1) prospectively tested positive for ctDNA using...

10.1158/1538-7445.am2025-ct131 article EN Cancer Research 2025-04-25
Coming Soon ...